CYL Corporation Berhad (KLSE:CYL)

Orchard Therapeutics Ratios and Metrics

Market cap in millions MYR. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	35	42	53	109	47	48
Market Cap Growth	-44.26%	-20.00%	-51.84%	131.91%	-1.05%	39.71%
Enterprise Value	30	36	45	101	39	40
Last Close Price	0.35	0.41	0.51	1.05	0.45	0.45
PE Ratio	29.05	-	-	-	34.75	29.58
PS Ratio	0.69	0.86	1.22	2.42	0.95	1.11
PB Ratio	0.31	0.38	0.86	1.72	0.74	0.75
P/TBV Ratio	0.31	0.38	0.86	1.72	0.74	0.75
P/FCF Ratio	152.25	-	-	49.65	74.42	47.54
P/OCF Ratio	47.99	19.18	37.59	32.91	17.98	16.45
EV/Sales Ratio	0.59	0.73	1.05	2.25	0.78	0.95
EV/EBITDA Ratio	2.02	2.31	3.93	8.15	2.72	2.71
EV/EBIT Ratio	2.12	2.86	5.22	10.54	3.48	3.51
EV/FCF Ratio	129.94	-	-	46.23	61.30	40.41
Debt / Equity Ratio	0.00	0.00	-	-	-	-
Debt / EBITDA Ratio	0.02	0.02	-	-	-	-
Asset Turnover	0.50	0.48	0.59	0.61	0.66	0.57
Inventory Turnover	5.93	4.91	4.87	5.24	5.76	3.56
Quick Ratio	3.64	2.55	3.06	4.11	3.05	2.23
Current Ratio	4.40	3.50	3.97	5.37	3.77	3.08
Return on Equity (ROE)	1.39%	-0.47%	-2.52%	-0.28%	2.14%	2.53%
Return on Assets (ROA)	8.70%	7.74%	7.41%	8.08%	9.20%	9.54%
Return on Capital (ROIC)	10.10%	9.03%	8.66%	9.49%	10.99%	11.35%
Return on Capital Employed (ROCE)	11.30%	10.10%	12.90%	13.90%	16.10%	16.80%
Earnings Yield	3.44%	-0.97%	-2.99%	-0.16%	2.88%	3.38%
FCF Yield	0.66%	-0.42%	-3.84%	2.01%	1.34%	2.10%
Dividend Yield	2.86%	1.21%	0.98%	-	2.21%	1.12%
Payout Ratio	41.49%	-	-	-	73.94%	31.13%
Total Shareholder Return	2.86%	1.21%	0.98%	-	2.21%	1.12%

Updated Dec 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.